All of the monoclonal antibodies they approved so far , are neutralizing antibodies , working directly on spike protein of this virus , but do nothing to this dangerous stage of COVID , immunological stage ..
I am really surprised they didn’t approve Leronlimab until now , this is so needed ..
Few months ago during interview with NEJM dr Woodcock was talking about it , how much they need drug acting on immunological stage of the disease ..
That was about 2 days after Dr Patterson published his papers about Montefiore patients , so I emailed this paper to dr Woodcock ,
She answered me that she read it already ..
So they are following leronlimab ..
Hopefully very soon ..